Metraipolis › archive › dc_46258bfcfb57

PARP inhibitors as radiosensitizers: a comprehensive review of preclinical evidence and clinical applications — Europe PMC PMID:41367875

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41367875
DOI
10.3389/fonc.2025.1702121
License (as archived)
solo-consultazione
Archived
2026-11-08T07:54:08.602Z
SHA-256 of the archived text
3791be904694ffc5979b28a1a7c5f5c94d5db82bdc1cba8dd9b8c8fc00b54d9e
Stable URL of this page
https://metraipolis.com/documento/dc_46258bfcfb57

How to cite

PARP inhibitors as radiosensitizers: a comprehensive review of preclinical evidence and clinical applications — Europe PMC PMID:41367875 — Europe PMC (en), https://europepmc.org/article/MED/41367875 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_46258bfcfb57 (Metraipolis archive dc_46258bfcfb57, sha256 3791be904694ffc5979b28a1a7c5f5c94d5db82bdc1cba8dd9b8c8fc00b54d9e)
BibTeX
@misc{dc46258bfcfb57,
  title = {PARP inhibitors as radiosensitizers: a comprehensive review of preclinical evidence and clinical applications — Europe PMC PMID:41367875},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41367875},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_46258bfcfb57; sha256 3791be904694ffc5979b28a1a7c5f5c94d5db82bdc1cba8dd9b8c8fc00b54d9e},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41367875. Agents can read the archived copy with the MCP tool read_document.